Birmingham Children's Hospital to lead new hepatitis treatmentpublished at 14:46 British Summer Time 24 August 2021
Birmingham Children's Hospital will lead a world-first programme to offer young children across England lifesaving antiviral tablets to treat hepatitis C.
The virus can cause liver cancer and other potentially life-threatening damage.
While thousands of adults have already been cured of the condition on the NHS, this is the first time children under 12 in the UK will be offered the treatment after it was approved by the European Medicines Agency (EMA).
Professor Deidre Kelly, a consultant paediatric hepatologist who is leading the programme, says: "For the first time anywhere in the world, children and young people with hepatitis C will receive care as part of a national programme, delivered close to their homes."
Patients aged between three and 18 will be given five antiviral tablets. They have two follow-up blood tests - one at the end of their treatment and another 24 weeks later - and if both are negative it means they are cured of the condition.